| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |